China Pharma Group Pays $1.2 Billion for Robust Sun Holdings
Published: Jun 28, 2012
June 27, 2012 -- China Pharmaceutical Group will pay $1.2 billion to acquire Robust Sun Holdings Ltd., a company that makes drugs for CNS diseases. The transaction will add to China Pharma’s presence in finished drugs and reduce its focus on intermediates and APIs. China Pharma will purchase Robust Sun from Joyful Horizon Ltd. All three entities are affiliated with Hony Capital, the Hong Kong-headquartered PE firm that is the largest in Asia. More details....
Stock Symbol: (HK: 1093)